From education to politics: a pan-European analysis of COVID-19 conspiracy theory influences

People’s belief in COVID-19-related conspiracy theories (CTs) In Europe.

Genmab makes two C-suite additions as COO leaves; James Sabry leads a revamped supporting cast at BioMarin

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 24, 2024

Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

Weight-loss drugs like tirzepatide (Zepbound) and semaglutide (Wegovy) may trigger eating disorders in certain patients, doctors warned. (NBC News) In a placebo-controlled phase III trial,

August 7, 2024

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders | Psychedelic Invest

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a biotech company focused on discovery and development

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.